HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial.
David A WohlChristoph D SpinnerJason FlammC Bradley HareSusanne Doblecki-LewisPeter J RuaneJean-Michel MolinaAnthony MillsCynthia BrinsonMoti RamgopalAmanda ClarkeGordon CrofootClaudia MartorellChristoph CarterStephanie CoxJ Carlo HojillaYongwu ShaoMoupali DasAlexander KintuJared M BaetenRobert M GrantKaram MounzerKenneth MayerPublished in: The lancet. HIV (2024)
Gilead Sciences.